Publications
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity2009 | First Faculty of Medicine
- Improvement of Insulin Sensitivity after Peroxisome Proliferator-Activated Receptor-α Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels2006 | First Faculty of Medicine, Third Faculty of Medicine
- Serum concentration FGF-21 - a new metabolic control in patients with obesity and diabetes mellitus 2nd type: the impact of dietary intervention and administration of PPAR-alpha agonistsPublication without faculty affiliation
- Serum concentrations of novel metabolic regulator FGF-21 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet and PPAR-alpha agonist treatmentPublication without faculty affiliation
- PPAR-alpha and insulin sensitivity: the role of endocrine function of adipose tissuePublication without faculty affiliation
- The influence of deep hypothermia on inflammatory status, tissue hypoxia and endocrine function of adipose tissue during cardiac surgery2014 | First Faculty of Medicine
- Laparoscopic Sleeve Gastrectomy Differentially Affects Serum Concentrations of FGF-19 and FGF-21 in Morbidly Obese Subjects2013 | First Faculty of Medicine
- The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules2010 | First Faculty of Medicine
- Comment on "Adiponectin and Resistin Gene Polymorphisms in Patients with Anorexia Nervosa and Obesity and Its Influence on Metabolic Phenotype" reply2010 | First Faculty of Medicine
- The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters2010 | First Faculty of Medicine
Loading network view...